KEY FEATURES
| Full Name | Epidermal Growth Factor |
|---|---|
| Synonym | URG, HOMG4, Beta-Urogastrone |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 7.8-500pg/mL |
| Sensitivity | 2.9pg/mL |
| Sample Type | Serum, plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse EGF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse EGF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse EGF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse EGF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse EGF. You can calculate the concentration of Mouse EGF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse EGF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 24.16 | 72.89 | 226.67 | 23.69 | 70.87 | 243.08 |
| Standard deviation | 1.29 | 3.76 | 8.3 | 1.57 | 4.03 | 9.67 |
| CV(%) | 5.32 | 5.16 | 3.66 | 6.64 | 5.69 | 3.98 |
RECOVERY
The recovery of Mouse EGF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-108 | 100 |
| EDTA plasma (n=8) | 88-98 | 93 |
| Cell culture media (n=8) | 91-106 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse EGF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with EGF ELISA Kits
| EGFR ELISA Kit | publications with EGF and EGFR |
| ERBB2 ELISA Kit | publications with EGF and ERBB2 |
| SRC ELISA Kit | publications with EGF and SRC |
| GRB2 ELISA Kit | publications with EGF and GRB2 |
| STAT3 ELISA Kit | publications with EGF and STAT3 |
| ERBB3 ELISA Kit | publications with EGF and ERBB3 |
| ERBB4 ELISA Kit | publications with EGF and ERBB4 |
| ADAM17 ELISA Kit | publications with EGF and ADAM17 |
| FN1 ELISA Kit | publications with EGF and FN1 |
Pathways associated with EGF ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Arf6 Signaling Events Pathway | Arf6 Signaling Events Pathway |
| Bladder Cancer Pathway | Bladder Cancer Pathway |
| Ceramide Signaling Pathway | Ceramide Signaling Pathway |
| Constitutive PI3K/AKT Signaling In Cancer Pathway | Constitutive PI3K/AKT Signaling In Cancer Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| DAP12 Interactions Pathway | DAP12 Interactions Pathway |
| DAP12 Signaling Pathway | DAP12 Signaling Pathway |
Diseases associated with EGF ELISA Kit
| Breast Neoplasms | publications with EGF and Breast Neoplasms |
| Adenocarcinoma | publications with EGF and Adenocarcinoma |
| Necrosis | publications with EGF and Necrosis |
| Cell Transformation, Neoplastic | publications with EGF and Cell Transformation, Neoplastic |
| Neoplasms, Experimental | publications with EGF and Neoplasms, Experimental |
| Lung Neoplasms | publications with EGF and Lung Neoplasms |
| Inflammation | publications with EGF and Inflammation |
| Neoplasm Metastasis | publications with EGF and Neoplasm Metastasis |
| Liver Diseases | publications with EGF and Liver Diseases |
| Neoplasm Invasiveness | publications with EGF and Neoplasm Invasiveness |
Organs/Tissues associated with EGF ELISA Kit
| Bone | publications with EGF and Bone |
| Connective Tissue | publications with EGF and Connective Tissue |
| Heart | publications with EGF and Heart |
| Muscle | publications with EGF and Muscle |
| Brain | publications with EGF and Brain |
| Vascular | publications with EGF and Vascular |
| Embryonic Tissue | publications with EGF and Embryonic Tissue |
| Ear | publications with EGF and Ear |
| Kidney | publications with EGF and Kidney |
| Umbilical Cord | publications with EGF and Umbilical Cord |